Precision IFX: Using a Dashboard to Individualize Infliximab Dosage
Clinical trial NCT02624037 · COMPLETED
Trial details
- NCT number
- NCT02624037
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-01
- Primary completion
- 2020-10-21
- Enrollment
- 189
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.